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MATERIALS AND METHODS
Antibodies.
A PE-conjugated mouse anti-human CD34 antibody and its isotype control were purchased from Miltenyi Biotec and a PE-Cyanine7-conjugated anti-human CD34 antibody from eBioscience. Mouse anti-human CD41/CD61 (ALMA.17), CD42b (ALMA.12) and CD42d (V.1) and rat anti-mouse and human CD42c (RAM.1) antibodies were produced, purified and fluorochrome-conjugated in our laboratory [24] [25] [26] [27] . Isotype controls, mouse and rat IgG1 (R3-34), were from Sigma-Aldrich and BD Bioscience respectively. An APCconjugated mouse anti-human IL-21Rα antibody (17A12) and its isotype control were from
Biolegend. An unconjugated mouse anti-human IL-21Rα antibody (152504) was from R&D Systems. Alexa Fluor® (Alexa) 647-conjugated mouse anti-phospho-Stat3 (4/P-STAT3) and Alexa488-conjugated mouse anti-phospho-Stat5 (Clone 47) antibodies were from BD Bioscience. A biotinylated goat anti-mouse IgG antibody was from Beckman Coulter. The humanized and neutralizing anti-IL-21R monoclonal antibody ATR-107 was kindly provided by Pfizer Inc.
Human CD34
+ cell isolation. Adult human peripheral blood cells were obtained with informed consent from healthy blood donors of the Etablissement Français du Sang-Alsace. The cells were recovered by elution from leukocyte depletion filters as previously described [28] . After 15 min incubation with RosetteSep® Human Granulocyte Depletion Cocktail (StemCell Technologies), mononuclear cells were isolated by Histopaque®-1077 (Sigma-Aldrich) density gradient separation for 30 min at 400g. CD34 + cells were separated from mononuclear cells using a CD34 MicroBead Kit and an AutoMACS™ device (Miltenyi Biotec) . The purity of the CD34 + cells was greater than 85% as measured by flow cytometry. The cells were counted and their viability was determined using an automatic cell counter and propidium iodide exclusion (ADAM, Digital-Bio, Korea). and 5'-ATTCCTCGTTGAAGAGCA-3' for IL21R, IL2RG and 18S respectively. The PCR products (5 µL) were separated on 2% (wt/vol) agarose gels and stained with 1/10,000 (v/v) GelRed Nucleic Acid Stain (BIOTIUM). Images of the stained gels were acquired using an
In vitro differentiation of
ImageQuant 350 system and analyzed using ImageQuantTL software (GE Healthcare). The numbers of cycles were empirically determined so that the PCR products were generated during the linear phase of amplification; in practice 14, 31 and 28 cycles were used to amplify 18S rRNA and IL21R and IL2RG cDNAs, respectively. The identities of the RT-PCR products were confirmed by DNA sequencing.
Immunofluorescence microscopy. Human bone marrow specimens having a normal megakaryocytic lineage were obtained with informed consent from individuals undergoing bone marrow aspiration from the iliac crest. The samples were fixed in 2% paraformaldehyde for 4 h, cryoprotected in 10% and then 20% sucrose solutions overnight at 4°C, embedded in OCT medium and cryosectioned at 8 µm. Cultured megakaryocytes at day 13 of culture were fixed in 2% paraformaldehyde for 15 min and cytospun onto poly L-lysine-coated slides. The samples were blocked for 1 h in PBS containing 100 mM glycine, 10% normal goat serum Mice were sacrificed and the murine femora, spleens and livers were harvested and fixed overnight in 4% paraformaldehyde. Femora were decalcified in 10% EDTA in water (wt/vol, pH 7.4) at 4°C. The organs were cryoprotected overnight at 4°C in 10% and then 20% sucrose solutions and embedded in OCT medium and 8 µm thick cryosections were prepared. The sections were fixed in ice cold acetone for 2 min, blocked for 1 h in PBS containing 100 mM glycine, 10% normal goat serum (Vector Laboratories) and 5% mouse FcR blocking reagent To inhibit IL-21R mediated signal transduction, ATR107 antibody (100 ng/ml) was added during the last 30 min of cytokine starvation. Cells were washed, stimulated with IL-21, then STAT3 phosphorylation was assessed using the same protocol.
Analysis of the phenotype of MKs. On days 7 and 12 of culture, cells were incubated for 2 h at 37°C with Hoechst 33342 and then stained with anti-CD34-PE-Cy7, -CD41-PE, -CD42c-Alexa 488 and -CD42d-Alexa 647 mAbs. The washed cells were resuspended in PBS containing 7-AAD and analyzed by flow cytometry.
Quantification of platelet release. On day 13 of culture, 1 µmol/L prostaglandin E1 (SigmaAldrich) and 0.02 U/mL apyrase, purified from potatoes as previously described [29] , were added to the culture medium and the cells were subjected to repetitive pipetting as previously of culture, 1 µmol/L prostaglandin E1 (Sigma-Aldrich) and 0.02 U/mL apyrase were added to the culture medium and the cells were subjected to repetitive pipetting as previously described [30] .
In vivo experiments in mice. Wild type C57BL/6J mice were obtained from Charles River
Laboratories, while the HR35 mouse strain (C57BL/6J background) ubiquitously expressing EGFP under the control of the beta-actin promoter was kindly provided by P Chambon (Strasbourg).
For in vivo expression, murine IL-21 cDNA was cloned into the pLIVE expression vector under the albumin promoter (Mirus Bio LLC). For hydrodynamic transfection, 2 mL of TransIT®-EE Delivery Solution (Mirus Bio LLC) containing empty or recombinant plasmids (10 µg/mL) were intravenously injected into 18 to 20 g male C57BL/6J mice (Liu et al., 1999) . At the indicated times, plasma samples were prepared from EDTA-anticoagulated blood and stored at -80°C.
The plasma concentration of IL-21 was measured by enzyme-linked immunoadsorbent assay (Mouse IL-21 ELISA Ready-SET-Go!®, eBioscience).
Mouse platelets. Blood samples were collected into EDTA anticoagulant (6 mM) from the tail of isoflurane-anesthetized mice. Platelet counts were determined using a Scil Vet abc Plus+ analyzer (HORIBA Medical). The blood samples were labeled with anti-IL-21Rα-PE and antiCD42c-Alexa 488 in the presence of an Fc blocking reagent. The percentage of reticulated platelets was determined by adding 2 µL of whole blood to 50 µL of PBS containing 6 mM EDTA, 1 µg/mL Thiazole Orange (Sigma-Aldrich) and 0.5 µg/mL anti-CD42c-Alexa 647. After incubation for 15 min, the cells were fixed in 500 µL of 1% paraformaldehyde and immediately analyzed by flow cytometry (a representative analysis is shown on Supplementary Figure 7) .
To measure platelet survival, washed EGFP + platelets (1.2x10 6 platelets/μL) were prepared from HR35 mice as previously described (Cazenave et al., 2004) and retro-orbitally injected into isoflurane-anesthetized mice, 5 days after hydrodynamic transfection (100 µL per mouse).
The ratio of EGFP + transfused to EGFP -endogenous platelets was determined by flow cytometric analysis of EDTA-anticoagulated blood samples drawn at the indicated times. was added to platelet suspension (10 µL each). Then, 5 µL 5 times concentrated agonist (AYPGKF peptide and U46619, PAR4 and thromboxane receptor agonist, respectively) in plain Tyrode buffer or the buffer alone were added. Platelets were incubated for 15 min at 37°C, then the reaction was stopped by adding 50 µL PAF 1.5% containing RAM1 mAb (anti Gp1bβ) conjugated to Alexa 555 (used in combination with anti-P-selectin labeling) or to Alexa647 (used in combination with JONA-PE mAb). 
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